239 related articles for article (PubMed ID: 2653154)
1. Diabetic nephropathy: hemodynamic basis and implications for disease management.
Noth RH; Krolewski AS; Kaysen GA; Meyer TW; Schambelan M
Ann Intern Med; 1989 May; 110(10):795-813. PubMed ID: 2653154
[TBL] [Abstract][Full Text] [Related]
2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
3. Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy.
Wang Y; Wang C; Zhang X; Gu HF; Wu L
Curr Diabetes Rev; 2018; 14(2):149-161. PubMed ID: 28201968
[TBL] [Abstract][Full Text] [Related]
4. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
Castellino P; Shohat J; DeFronzo RA
Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280
[TBL] [Abstract][Full Text] [Related]
5. Current concepts of renal hemodynamics in diabetes.
Anderson S; Vora JP
J Diabetes Complications; 1995; 9(4):304-7. PubMed ID: 8573753
[TBL] [Abstract][Full Text] [Related]
6. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
7. Glomerular dysfunction in diabetic nephropathy.
Zucchelli P; Zuccalà A; Sturani A
Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
[TBL] [Abstract][Full Text] [Related]
8. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
9. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for the management of special populations: renal disease in diabetes.
Raij L
Am J Hypertens; 2003 Nov; 16(11 Pt 2):46S-49S. PubMed ID: 14625161
[TBL] [Abstract][Full Text] [Related]
11. Progression of renal failure in diabetic nephropathy.
Marcantoni C; Ortalda V; Lupo A; Maschio G
Nephrol Dial Transplant; 1998; 13 Suppl 8():16-9. PubMed ID: 9870420
[TBL] [Abstract][Full Text] [Related]
12. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
13. [Prediction, screening and treatment of renal complications of diabetes].
Marre M; Larger E
Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
Baba T; Ishizaki T
Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
[TBL] [Abstract][Full Text] [Related]
15. [Risk and prevention of diabetic nephropathy].
Ravera M; Re M; Deferrari G
G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
Thomas MC; Atkins RC
Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
[TBL] [Abstract][Full Text] [Related]
17. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
18. Prevention of loss of renal function over time in patients with diabetic nephropathy.
Barnett A
Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
[TBL] [Abstract][Full Text] [Related]
19. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
Raij L
Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
[TBL] [Abstract][Full Text] [Related]
20. SGLT2 Inhibitors and the Diabetic Kidney.
Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R
Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
